Skip to main content Skip to Navigation menu Skip to Login form
Skip to main content Skip to top of page
Skip to Navigation menu Skip to top of page
Patrick Duxbury and Emma Tuck ask whether the increasing cost of drug development, and the declining numbers of drugs being approved, mean that IP protection for life science products should be reevaluated
James Malackowski, founder and CEO of patent auction company, Ocean Tomo, has been at the helm of a unique and increasingly lucrative IP business model. Eileen McDermott asked him how he got here, what's in store for the future and what the new US president should do for innovation
Effective supervision and management is crucial for any successful IP owner. But which tools will work best for you? In Managing IP's third annual software survey, Rocco Colella outlines the options
The Enlarged Board decision on the patentability of computer programs will bring welcome clarity
Maintaining consistency and ensuring stability in the patent examination process are crucial to the issuance of quality patents. Marian Underweiser of IBM proposes one way to make the process more predictable
The EPO's Enlarged Board of Appeal is set to give a definitive ruling on the patentability of computer programs in Europe
In the Bilski decision, the Federal Circuit last month reaffirmed that business methods are patentable in the US, but rejected the "useful, concrete, tangible" test set forth in previous opinions
The Federal Circuit last month ruled that the ITC could not extend a limited exclusion order barring the import of Qualcomm chips found to infringe Broadcom's patent to downstream products
US Magistrate Judge Stephen Crocker has recently taken on a bigger role at the nation's latest patent rocket-docket. Eileen McDermott spoke to him about how the Court will continue to handle the heavy patent caseload minus one judge, as well as what the future holds
This month, Francis Gurry takes over the role of WIPO director general, as the world's only international organisation dedicated to intellectual property begins its recovery from a period of criticism and stagnation. In an exclusive interview, he discusses the challenges WIPO faces, the changes he will make and why he is the right man for the most important job in IP
The European Patent Office has talked about raising the bar, and its allowance rate has fallen in recent years. Hugh Dunlop asks: what’s really going on at the Office?
The Supreme Court's eBay decision made it harder for patent trolls to obtain injunctions. Bas de Blank and Fabio Marino explain why the ITC may give them an escape route
Pharmaceutical companies are adopting new IP strategies to stay competitive. Rakesh Mishra and GVS Sesha Kumar review some of the most successful examples
Managing IP asked correspondents in six jurisdictions that either have, or are considering introducing, pre- or post-grant opposition to address the key questions for patent owners
The Federal Circuit last month threw out the established test for design patent infringement in the US in what many are heralding as a long overdue shift in the design patent landscape
China's National People's Congress has published the latest draft of amendments to its patent law. Managing IP provides a guide to what may change
Professor John Duffy made three predictions about the patent system in Managing IP's first e-symposium last month
The world is beginning to face up to the threat of climate change. But meeting the climate challenge will above all require the development of new technologies. James Nurton asks: can patents save the planet? Plus: clean tech case studies, green branding and the Green IP Award
As more and more US courts become patent-savvy, it is important to understand the procedural differences between the main venues. Authors in five districts and the ITC answer your questions
The pre-trial Markman hearing that is standard in US patent infringement cases can provide parties the opportunity to bypass expensive litigation. Andrew Piatnicia explains how to maximise the possibilities
The EU directive to introduce a US-style Bolar provision promised to harmonise the law on clinical trials. But, says Marina Barnden, inconsistent application has led to uncertainty
Peter Ollier talks to Vincent Zhong, vice president of Netac Technology, the first Chinese company to sue an American rival in the US for patent infringement
Everyone likes to win prizes – especially when they are worth $300 million. That is the amount that US presidential candidate John McCain has proposed offering as an award to the inventor of a cheap, powerful car battery that will "leapfrog" existing commercial products
Taiwan's Intellectual Property Office is to amend the compulsory licensing provisions of its Patent Law after a long-running dispute between a local CD maker and Philips finally ended
The Federal Circuit will hear one of its most controversial cases before the end of 2008, as the USPTO appeals a lower district court ruling that its rule changes were unlawful
The House of Lords made its most important patent ruling in recent times when it clarified the test for obviousness in the UK. How have other courts dealt with this issue?
The Supreme Court's decision in Quanta v LG could make it harder for licensors to collect downstream royalties. Eileen McDermott explores the implications
With IP reforms being discussed around the world, this year's selection of the most influential people in IP features many politicians and campaigners. But there are also a few surprises
China's long-awaited Anti-Monopoly law comes into effect on August 1, but its impact on IP owners is far from certain, explain Kirstie Nicholson and Zirou Liu
Attorney-client privilege is an increasingly contentious issue worldwide. Jochen Bühling and Michael Jewess introduce a series of jurisdiction-based Q&A articles
IP licensing is a key tool in any company's belt. But several recent Supreme Court decisions could make the process trickier, say Edward E Vassallo and Swatee Jasoria
Ewa M Davison and Gary M Myles provide strategies for establishing non-obviousness in the biotechnology and pharmaceutical arts in light of the Supreme Court’s rejection of a rigid TSM test
Hewlett-Packard was last month ordered by a jury to pay $184 million to Cornell University for patent infringement
Judges focused on whether or not to maintain the point of novelty test for determining design patent infringement in last month's hearing in Egyptian Goddess v Swisa
Procter & Gamble, Max Planck Innovation and the Catholic University of Leuven have been recognized for their achievements in technology transfer
he USPTO's peer-to-patent project has led to an increase in prior art submissions but has failed to bring in fresh patent applications in its first year
Branded and generic drugs companies could be more willing to compromise on IP rights, following the Pfizer/Ranbaxy settlement over Lipitor
1968 saw a social revolution in Paris. Forty years on, there is the potential for another memorable achievement in the city
It has been just over three decades since the first biotechnology company - Genentech - was formed in 1976. Since then biotechnology has become a multi-billion dollar industry with ground-breaking products, based on original research. Eklavya Gupte examines five patents that have shaped the sector
Horng-Dar Lin explains how Taiwanese companies that used only to manufacture for foreign businesses are developing their own brand identities
An Australian court has considered the issue of who owns IP generated by employees. Suzy Groom puts the decision in context
Eileen McDermott spoke to former USPTO solicitor and counsel to the Senate Judiciary Committee on the Patent Reform Act John Whealan about patent reform in the US
European Commission vice-president Günter Verheugen last month called for a Community patent and single litigation system
The Federal Circuit last month examined terms such as "tangible", "abstract", "concrete" and "transformative", in the closely watched In re Bilski hearing
From Shamnad Basheer
From Varun Chhonkar
At a recent web seminar organized in conjunction with Finnegan Henderson, two private practitioners, an in-house lawyer and an attorney at the International Trade Commission explained how plaintiffs and defendants can navigate their way around the rules
Four pharmaceutical patent cases being argued in India will have a big impact on healthcare issues in the region. Peter Ollier looks at what is at stake
Mistakes made in the patent drafting process can come back to haunt litigants in the court room. Martin Sulsky and Raj S Davé explain how to avoid common drafting errors
Interview: As Microsoft's global vice-president of IP and licensing, Horacio Gutierrez plays an integral role in protecting the company's IP rights
A leading UK judge has called for a "one-stop patent shop" to cater to companies that do business across Europe, after finding a patent invalid just days after it was upheld by a court in the Netherlands
A court in Taipei has overturned a decision by the local IP office to grant compulsory licences to a Taiwanese company for five patents owned by Philips
Subscriber login:
CURRENT ISSUE:
December 2008 / January 2009
COVER STORY: The IP world goes flat
Companies can save a lot of money by outsourcing their IP work, but it takes time and effort to get the process right. Peter Ollier assesses the options
CURRENT ISSUE: